Company Intelligence

allumbra

allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a…

Official Website Products
In this profile

Quick Facts

  • Founded 2026
  • Headquarters Broomfield, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars AI Health Baltimore
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a market with limited options

Why It Matters

allumbra appears in the public Techstars AI Health Baltimore portfolio (open accelerator dataset).

Products

Enterprise Software

allumbra

allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to…

View Product

Recent Developments

  1. 2026 Company founded

    allumbra was founded in 2026 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

AI in Enterprise Software Open industry

allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a market with limited options

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Request a correction if you represent this company or believe information is inaccurate.

Explore Related Intelligence

Products Product directory Founders Founder profiles Reports Open reports Industries Explore sectors

The AI Brief

Weekly company intelligence in your inbox.

Subscribe